# Paper Writing Skills Progress

## Score Trend
| Iteration | Paper | Accuracy | Completeness | Logic | Readability | Structure | Clinical | Overall |
|-----------|-------|----------|--------------|-------|-------------|-----------|----------|---------|
| 1         | Lyu 2024 (Myopia/Referral) | 4.8 | 5.6 | 7.2 | 7.4 | 6.4 | 5.8 | **5.2** |
| 2         | TVC Study 11yr (Glaucoma Surgery) | 9.0 | 7.3 | 9.0 | 8.9 | 9.0 | 7.9 | **8.5** |
| 3         | DR-AMD Taiwan NHIRD (Retina) | 9.2 | 7.7 | 9.0 | 8.8 | 9.1 | 8.3 | **8.7** |
| 4         | Anti-VEGF/ONH Parameters (Cross-sectional) | 9.5 | 8.2 | 9.0 | 9.0 | 9.5 | 8.5 | **8.9** |
| 5         | DR Progression Primary Care (Longitudinal) | 9.5 | 8.5 | 9.0 | 9.0 | 9.5 | 8.5 | **9.0** |
| 6         | KC Risk Factors (Case-Control, All of Us) | 10.0 | 8.5 | 9.5 | 9.0 | 9.5 | 8.5 | **9.1** |
| 7         | BlephEx Blepharitis (Sham-Controlled RCT) | 10.0 | 7.0 | 9.0 | 9.0 | 9.5 | 9.0 | **8.8** |

## Summary After 7 Iterations
- **Total improvement**: 5.2 -> 9.1 peak, current 8.8 (+3.6 points, +69%)
- **Total rules accumulated**: 56 (15 from Iter1, 6 from Iter2, 9 from Iter3, 7 from Iter4, 6 from Iter5, 7 from Iter6, 6 from Iter7)
- **Numerical accuracy**: 0% (Iter1) -> 100% (Iter2-7, 6 consecutive)
- **Blind integrity**: PASS (Iter4), PASS (Iter5), PASS (Iter6), PASS (Iter7)
- **Study designs covered**: Prospective cohort, RCT follow-up, retrospective database, cross-sectional, longitudinal observational, case-control, sham-controlled device RCT
- **Primary bottleneck**: Discussion scholarly depth when original has extensive literature comparisons not available in extracted data bundle

## Iteration 1
- **Paper**: Lyu et al. (2024) "Impact of ophthalmic clinical service use in mitigating myopia onset and progression in preschool children" - BMC Ophthalmology 24, 221
- **Quality Score**: 5.2/10
- **Key Gaps**:
  - Critical numerical inaccuracies (group sizes wrong)
  - Data conflation between analytic subgroups
  - Under-developed Discussion, missing methodological detail
  - Fabricated references (22 AI-generated citations)
- **Strengths**: Strong Introduction structure, High readability
- **New Rules Added**: 15 (5 high, 9 medium, 1 low)
- **Key Lesson**: Prioritize data verification over stylistic polish.

## Iteration 2
- **Paper**: Verma-Fuehring et al. (2025) "Long-term outcomes of trabeculectomy versus canaloplasty in open-angle glaucoma – an 11-year follow-up" - BMC Ophthalmology
- **Quality Score**: 8.5/10 (+3.3 improvement)
- **Key Improvements**:
  - 100% numerical accuracy (34/34 data points correct)
  - No fabricated references
  - Instrument names and protocols included
  - Results kept strictly descriptive
  - Discussion with 6+ thematic paragraphs
- **Remaining Gaps**: Incomplete references, missing baseline demographics, limited international comparisons
- **New Rules Added**: 6
- **Key Lesson**: Web extraction limitations primarily affect reference completeness and table data.

## Iteration 3
- **Paper**: Lin et al. (2024) "The Association between Diabetic Retinopathy and Macular Degeneration: A Nationwide Population-Based Study" - Biomedicines (PMC11047965)
- **Quality Score**: 8.7/10 (+0.2 improvement)
- **Key Improvements**:
  - 100% numerical accuracy maintained (17/17 correct)
  - Discussion expanded to 7 thematic subsections (up from 6)
  - Better integration of verified prior literature (2018 Diabetes Care study, Kailuan Eye Study)
  - Comprehensive Limitations (5 points including surveillance bias)
  - Structured Abstract with quantitative results
  - Dedicated Ethics Statement subsection
- **Remaining Gaps**:
  - Incomplete Table 1 (exact comorbidity percentages not extractable)
  - Missing unadjusted hazard ratios
  - No formal numbered reference list
- **New Rules Added**: 9
- **Key Lesson**: Pipeline now reliably produces 100% accurate drafts across study designs. Score ceiling determined by extraction depth, not methodology.

## Iteration 4
- **Paper**: Anti-VEGF intravitreal injections and optic nerve head parameters (Cross-sectional study)
- **Quality Score**: 8.9/10 (+0.2 improvement)
- **Blind Integrity**: PASS
- **Key Improvements**:
  - 100% numerical accuracy maintained (28/28 correct)
  - First blind writing iteration with anonymized data bundle
  - Zero knowledge leakage, zero verbatim phrase overlap
  - Superior structural organization vs. original (6 Methods subsections, 5 formal tables)
  - Clean blind integrity: independently structured throughout
- **Remaining Gaps**:
  - Limited Discussion depth (unable to match original's named study comparisons)
  - General-knowledge numerical claims without verifiable sources
  - Verbosity (60% longer than original)
- **New Rules Added**: 7
- **Key Lesson**: Blind writing pipeline works -- independently structured paper with no evidence of accessing original. Key remaining gaps: controlling general-knowledge claims and maintaining conciseness.

## Iteration 5
- **Paper**: Lalwani et al. (2025) "Progression of diabetic retinopathy in a longitudinal real-world study of patients in primary care" - BMC Ophthalmology
- **Quality Score**: 9.0/10 (+0.1 improvement)
- **Blind Integrity**: PASS
- **Key Improvements**:
  - 100% numerical accuracy maintained (50/50 correct) -- largest data point count verified to date
  - Strong structural originality: Introduction (3 vs 2 paragraphs), Methods (7 vs 4 subsections), Discussion (9 vs 3 subsections)
  - Complete Table 1 with all 13 baseline DRSS levels
  - All 7 figure legends accurately reproduced
  - Second consecutive blind integrity PASS
- **Remaining Gaps**:
  - Verbosity (~35-40% longer than original) with Discussion-Conclusions redundancy
  - Missing clinical trial benchmark comparisons (PANORAMA, Protocol W) -- extraction-limited
  - Missing supplementary material references and clinical guideline connections
  - Discussion literature comparisons lack quantitative specificity
- **New Rules Added**: 6
- **Key Lesson**: Pipeline achieves 9.0/10 across 5 study designs with 4th consecutive 100% accuracy. Improvement ceiling now determined by Discussion clinical contextualization and verbosity control, not accuracy or structural issues. The 6 new rules target redundancy elimination, benchmark referencing, and guideline integration.

## Iteration 6
- **Paper**: Beatty et al. (2024) "Exploring New Links Among Keratoconus, Hormonal Factors, and Medications: Insights From a Case-Control Study Utilizing the All of Us Database" - Translational Vision Science & Technology
- **Quality Score**: 9.1/10 (+0.1 improvement)
- **Blind Integrity**: PASS
- **Key Improvements**:
  - 100% numerical accuracy maintained (50/50 correct) -- 5th consecutive perfect accuracy
  - Excellent structural originality with independently organized Discussion (7 themed subsections vs. original's 5 unheaded paragraphs)
  - Complete Table 1 and Table 2 with all demographic and multivariable results
  - Third consecutive blind integrity PASS -- zero knowledge leakage, zero phrasing overlap, substantially different Discussion ordering
  - Improved logical flow score (9.5, up from 9.0) with strong funnel Introduction
- **Remaining Gaps**:
  - Discussion verbosity (~50-60% longer than original) with extensive speculative mechanistic content
  - Missing clinically actionable Conclusions (calls for "further investigation" only)
  - Missing fine-grained details: specific medication identities within grouped variables, disease stage implications for older cohort, appendix references
  - Translational Relevance section (TVST-specific) absent
- **New Rules Added**: 7
- **Key Lesson**: Pipeline achieves 9.1/10 across 6 study designs with 5th consecutive 100% accuracy and 3rd consecutive blind integrity PASS. Improvement rate slowing (0.1/iteration), suggesting approach to ceiling. Key remaining targets: (1) concise mechanistic discussion, (2) clinically actionable conclusions, (3) fine-grained clinical detail capture. The 7 new rules address Discussion brevity, clinical action statements, medication specifics, appendix references, disease stage limitations, coding system specificity, and novel-findings-first Discussion ordering.

## Iteration 7
- **Paper**: Siegel et al. (2024) "BlephEx-treatment for blepharitis: a prospective randomized placebo-controlled trial" - BMC Ophthalmology 24, PMC11575124
- **Quality Score**: 8.8/10 (-0.3 from Iteration 6)
- **Blind Integrity**: PASS
- **Key Results**:
  - 100% numerical accuracy maintained (56/56 correct) -- 6th consecutive perfect accuracy, largest data point count verified to date
  - Fourth consecutive blind integrity PASS with zero knowledge leakage
  - Superior Clinical Implications section exceeding original's single-sentence conclusion
  - New study design covered: sham-controlled device/procedural RCT
- **Score Decrease Cause**: Discussion completeness gap. The original contains detailed comparisons with 8+ named studies that could not be replicated from the anonymized data bundle, resulting in a draft Discussion approximately 50% shorter than the original.
- **Remaining Gaps**:
  - Missing named literature comparisons (8+ studies in original Discussion)
  - Missing unmeasured mechanistic endpoint limitations
  - Missing zero-prevalence Table 1 rows and figure references
  - Word count ratio 0.57 (substantially under 0.95-1.15 target)
- **New Rules Added**: 6
- **Key Lesson**: This iteration reveals the pipeline's vulnerability to literature-rich Discussion sections. When the original paper devotes extensive space to named study comparisons not available in the data bundle, the draft inevitably undershoots on completeness. The 6 new rules address this by encouraging framework-level literature contextualization, intervention-class mechanism discussion, unmeasured endpoint limitations, Discussion length monitoring, figure referencing, and zero-prevalence row retention. The score decrease is paper-specific rather than systemic -- the pipeline's core strengths (accuracy, blind integrity, structural organization, clinical actionability) remain undiminished.
